Department of Veterans Affairs Awarded a Contract to NOVARTIS PHARMACEUTICALS CORPORATION for $231,396.00

Q: Where is NOVARTIS PHARMACEUTICALS CORPORATION located?

59 ROUTE 10 EAST HANOVER NEW JERSEY UNITED STATES

Signed on

7/7/2025, 12:00 AM

NOVARTIS PHARMACEUTICALS CORPORATION Government Contract #36C24725F0260

NOVARTIS PHARMACEUTICALS CORPORATION was awarded a contract with the United States Government for $231,396.00. The contract was awarded by the agency office 247-NETWORK CONTRACT OFFICE 7 (36C247), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Novartis Pharmaceuticals Corporation, a U.S.-owned business based in New Jersey, who specializes in pharmaceutical preparation manufacturing. The contract, funded by the Department of Veterans Affairs, is for pharmacy services valued at $46,279.20. One notable transaction was recorded on July 7, 2025, for the same amount.

Contract Details

Contract ID36C24725F0260

Contract TypeC

Total Obligation$46,279.20

Exercised Options$46,279.20

Base Amount + Options$231,396.00

Date Signed2025-07-07

Contract DescriptionGA-68 NETSPOT

Start Date2025-10-01

End Date2026-09-30

Agency Details

Awarding AgencyDepartment of Veterans Affairs

Awarding Sub AgencyDepartment of Veterans Affairs

Awarding Office247-NETWORK CONTRACT OFFICE 7 (36C247)

Funding AgencyDepartment of Veterans Affairs

Funding Sub AgencyDepartment of Veterans Affairs

Funding Office247-NETWORK CONTRACT OFFICE 7 (36C247)

Recipient Details

RecipientNOVARTIS PHARMACEUTICALS CORPORATION

Recipient Location59 ROUTE 10 EAST HANOVER NEW JERSEY, UNITED STATES

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0 | $46,279.20July 7, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $46,279.20 to NOVARTIS PHARMACEUTICALS CORPORATION. The payment included a Subsidy Cost of $0.00.